Commissariat à l'Énergie Atomique et aux Énergies Alternatives
发明人:
申请号：
EP11306407.5
公开号：
EP2586436A1
申请日:
2011.10.31
申请国别(地区):
EP
年份:
2013
代理人:
摘要：
This invention relates to improvements in therapeutic neurological and neuropsychic treatments using acetylcholinesterase inhibitors. More specifically, the invention enables the effects of the reversible acetylcholinesterase inhibitor donepezil to be potentiated by certain molecules, referred to here as connexin-blocking agents. Said connexin-blocking agent is preferably meclofenamic acid.
